{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:42:40Z","timestamp":1781091760793,"version":"3.54.1"},"reference-count":107,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["dom-pubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:label\/>\n                    <jats:p>Metabolic dysfunction\u2010associated fatty liver disease (MAFLD), formerly known as nonalcoholic fatty liver disease (NAFLD), is a common, highly heterogeneous condition that affects about a quarter of the world's population, with no approved drug therapy. Current evidence from preclinical research and a number of small clinical trials indicates that SGLT2 inhibitors could also be effective for MAFLD. MAFLD is associated with a higher risk of chronic liver disease and multiple extrahepatic events, especially cardiovascular disease (CVD) and chronic kidney disease (CKD). MAFLD is considered a more appropriate terminology than NAFLD because it captures the complex bidirectional interplay between fatty liver and metabolic dysfunctions associated with disease progression, such as obesity and type 2 diabetes mellitus (T2DM). SGLT2 inhibitors are antidiabetic drugs that block glucose reabsorption in the kidney proximal tubule. In this article, we reviewed current clinical evidence supporting the potential use of SGLT2 inhibitors as a drug therapy for MAFLD and discussed the possible cellular and molecular mechanisms involved. We also reviewed the clinical benefits of SGLT2 inhibitors against MAFLD\u2010related comorbidities, especially CVD, CKD and cardiovascular\u2013kidney\u2013metabolic syndrome (CKM). The broad beneficial effects of SGLT2 inhibitors support their use, likely in combination with other drugs, as a therapy for MAFLD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dom.16043","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T04:35:05Z","timestamp":1730954105000},"page":"457-467","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The cellular and molecular mechanisms mediating the protective effects of sodium\u2013glucose linked transporter 2 inhibitors against metabolic dysfunction\u2010associated fatty liver disease"],"prefix":"10.1111","volume":"27","author":[{"given":"Na","family":"Ao","sequence":"first","affiliation":[{"name":"Department of Endocrinology The Fourth Affiliated Hospital of China Medical University  Shenyang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Endocrinology The Fourth Affiliated Hospital of China Medical University  Shenyang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology The Fourth Affiliated Hospital of China Medical University  Shenyang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linna","family":"Suo","sequence":"additional","affiliation":[{"name":"Department of Endocrinology The Fourth Affiliated Hospital of China Medical University  Shenyang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4909-6714","authenticated-orcid":false,"given":"Jing","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology The Fourth Affiliated Hospital of China Medical University  Shenyang China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnz009"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.11.312"},{"key":"e_1_2_13_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-023-10568-z"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15422"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-022-10408-6"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hbpd.2022.05.007"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.06.003"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.07.021"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13856"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2309000"},{"key":"e_1_2_13_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2019.05.002"},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13425"},{"key":"e_1_2_13_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-024-10698-y"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2805103"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00055.2009"},{"key":"e_1_2_13_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2015.09.005"},{"key":"e_1_2_13_18_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.2016.1168808"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-019-0828-y"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2018.10.009"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4654-7"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.14797\/mdcvj.1120"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2017.07.002"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S184767"},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-0165"},{"key":"e_1_2_13_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000855"},{"key":"e_1_2_13_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4675-2"},{"key":"e_1_2_13_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13520"},{"key":"e_1_2_13_29_1","first-page":"843","article-title":"Empagliflozin improves liver steatosis and fibrosis in patients with non\u2010alcoholic fatty liver disease and type 2 diabetes: a randomized, double\u2010blind","volume":"12","author":"Chehrehgosha H","year":"2021","journal-title":"Placebo\u2010Controlled Clinical Trial Diabetes Ther"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-019-5477-1"},{"key":"e_1_2_13_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13304"},{"key":"e_1_2_13_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1696"},{"key":"e_1_2_13_33_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9010259"},{"key":"e_1_2_13_34_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-2049"},{"key":"e_1_2_13_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001990"},{"key":"e_1_2_13_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13236"},{"key":"e_1_2_13_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23527"},{"key":"e_1_2_13_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19658-7"},{"key":"e_1_2_13_39_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16874"},{"key":"e_1_2_13_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31193"},{"key":"e_1_2_13_41_1","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqab157"},{"key":"e_1_2_13_42_1","first-page":"121","article-title":"Emerging roles of SGLT2 inhibitors in obesity and insulin resistance: focus on fat browning and macrophage polarization","volume":"7","author":"Xu L","year":"2018","journal-title":"Adipocyte"},{"key":"e_1_2_13_43_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146337"},{"key":"e_1_2_13_44_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151511"},{"key":"e_1_2_13_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2018.03.043"},{"key":"e_1_2_13_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/jphp.12223"},{"key":"e_1_2_13_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2019.110539"},{"key":"e_1_2_13_48_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020818"},{"key":"e_1_2_13_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-016-0169-x"},{"key":"e_1_2_13_50_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21144908"},{"key":"e_1_2_13_51_1","first-page":"9","article-title":"Role of ferroptosis in non\u2010alcoholic fatty liver disease and its implications for therapeutic strategies","volume":"9","author":"Zhang H","year":"2021","journal-title":"Biomedicine"},{"key":"e_1_2_13_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1678-y"},{"key":"e_1_2_13_53_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-021-01346-y"},{"key":"e_1_2_13_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2022.12.088"},{"key":"e_1_2_13_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-022-01031-0"},{"key":"e_1_2_13_56_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI169922"},{"key":"e_1_2_13_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30834"},{"key":"e_1_2_13_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44026-z"},{"key":"e_1_2_13_59_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101426R"},{"key":"e_1_2_13_60_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012325"},{"key":"e_1_2_13_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.08.008"},{"key":"e_1_2_13_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-33086-2"},{"key":"e_1_2_13_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19152"},{"key":"e_1_2_13_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14233"},{"key":"e_1_2_13_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-020-01314-y"},{"key":"e_1_2_13_66_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232416107"},{"key":"e_1_2_13_67_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910606"},{"key":"e_1_2_13_68_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M800509-JLR200"},{"key":"e_1_2_13_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00335-009-9217-2"},{"key":"e_1_2_13_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101581"},{"key":"e_1_2_13_71_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3652"},{"key":"e_1_2_13_72_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI63539"},{"key":"e_1_2_13_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29885"},{"key":"e_1_2_13_74_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0261310"},{"key":"e_1_2_13_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155657"},{"key":"e_1_2_13_76_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-017-2509-x"},{"key":"e_1_2_13_77_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.922993"},{"key":"e_1_2_13_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2016.09.013"},{"key":"e_1_2_13_79_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i44.16452"},{"key":"e_1_2_13_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/brv.12178"},{"key":"e_1_2_13_81_1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2862173"},{"key":"e_1_2_13_82_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-018-0479-8"},{"key":"e_1_2_13_83_1","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2014.918533"},{"key":"e_1_2_13_84_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1117644"},{"key":"e_1_2_13_85_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1026040"},{"key":"e_1_2_13_86_1","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2020.1842990"},{"key":"e_1_2_13_87_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-018-0708-x"},{"key":"e_1_2_13_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2022.159234"},{"key":"e_1_2_13_89_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu14173531"},{"key":"e_1_2_13_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116167"},{"key":"e_1_2_13_91_1","article-title":"Nonalcoholic fatty liver disease: an emerging modern\u2010day risk factor for cardiovascular disease","volume":"14","author":"Hassen G","year":"2022","journal-title":"Cureus"},{"key":"e_1_2_13_92_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.akdh.2023.04.001"},{"key":"e_1_2_13_93_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15500"},{"key":"e_1_2_13_94_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001186"},{"key":"e_1_2_13_95_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01937-x"},{"key":"e_1_2_13_96_1","first-page":"1034","article-title":"Association between metabolic dysfunction\u2010associated fatty liver disease and cognitive impairment","volume":"10","author":"Yu Q","year":"2022","journal-title":"J Clin Transl Hepatol"},{"key":"e_1_2_13_97_1","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S258593"},{"key":"e_1_2_13_98_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00607-4"},{"key":"e_1_2_13_99_1","first-page":"136","article-title":"Association between serum uric acid and non\u2010alcoholic fatty liver disease: a meta\u2010analysis","volume":"49","author":"Darmawan G","year":"2017","journal-title":"Acta Med Indones"},{"key":"e_1_2_13_100_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.30885"},{"key":"e_1_2_13_101_1","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.13564"},{"key":"e_1_2_13_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.03.006"},{"key":"e_1_2_13_103_1","first-page":"8","article-title":"Epidemiology, screening, and co\u2010management of type 2 diabetes mellitus and metabolic dysfunction\u2010associated steatotic liver disease","author":"Qi X","year":"2024","journal-title":"Hepatology"},{"key":"e_1_2_13_104_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-023-03586-1"},{"key":"e_1_2_13_105_1","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.131"},{"key":"e_1_2_13_106_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2023.8029"},{"key":"e_1_2_13_107_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-023-02246-6"},{"key":"e_1_2_13_108_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-023-02948-4"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/dom.16043","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/full-xml\/10.1111\/dom.16043","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/dom.16043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T23:52:31Z","timestamp":1775865151000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/dom.16043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":107,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1111\/dom.16043"],"URL":"https:\/\/doi.org\/10.1111\/dom.16043","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1111\/DOM.16043\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.16043\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.16043\/v1\/review3","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.16043\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.16043\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.16043\/v1\/review1","asserted-by":"object"}]},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"assertion":[{"value":"2024-09-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}